IP Library › Granted Patent US 8,835,383
Granted Patent B2
US 8,835,383 · App. 13/266,409 · Granted Sep 16, 2014

Method for controlling the digestive coagulation of proteins

Inventors: Thomas Ludwig (Wageningen, NL); Claudia Catharina Maria van den Braak (Wageningen, NL); Marianne Klebach (Wageningen, NL); Zandrie Hofman (Wageningen, NL)
Assignee: N.V. Nutricia
A23L1/296A23L1/3055A23L1/3056A61K36/48A61K38/018A61K38/168A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,835,383
App. No.
13/266,409
Granted
Sep 16, 2014
Kind
B2
Abstract

This invention relates to the coagulation of protein containing nutritional compositions in the upper gastro-intestinal tract, more in particular in the stomach and provides a method for reducing suchcoagulation.

Claims (10)

1. A method of providing nutrition to a human subject in need of tube feeding, the method comprising administering to the subject by tube feed a nutritional composition comprising:

(a) 70-85 wt % coagulating protein; and

(b) 15-30 wt % non-coagulating protein consisting of pea protein and/or soy protein wherein the non-coagulating protein prevents or reduces the coagulation of the coagulating protein in the upper gastro-intestinal tract.

2. The method according to claim 1 , wherein the coagulating protein comprises dairy protein.

3. The method according to claim 1 , wherein the coagulating protein comprises caseinate.

4. The method according to claim 1 , wherein the non-coagulating pea or soy protein is hydrolyzed.

5. The method according to claim 1 , wherein the subject suffers from digestive tract complications.

6. The method according to claim 5 , wherein the subject is an infant or a toddler.

7. The method according to claim 1 , wherein the subject suffers from upper gastrointestinal conditions or complications selected from the group consisting of reflux, aspiration pneumonia, high gastric residual volume (GRV), vomiting, nausea, bloating, gastrointestinal cramping, colics, and delayed gastric emptying.

8. The method according to claim 1 , wherein the non-coagulating protein consists of pea protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2012
From: LUDWIG, THOMAS; VAN DEN BRAAK, CLAUDIA CATHARINA MARIA; KLEBACH, MARIANNE; HOFMAN, ZANDRIE
To: N.V. NUTRICIA
Reel/Frame 027496/0780 →
Priority Claims (1)
NL PCT/NL2009/050227 · Apr 27, 2009 · national
Continuity (1)
Related Publication 20120094901A1 · Apr 19, 2012